International Consensus Conference on High-Dose Therapy with Hematopoietic Stem-Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: Report of jury

被引：24

作者：

Shipp, MA

Abeloff, MD

Antman, KH

Carroll, G

Hagenbeek, A

Loeffler, M

Montserrat, E

Radford, JA

Salles, G

Schmitz, N

Symann, M

Armitage, JO

Coiffier, B

Philip, T

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Johns Hopkins Univ, Sch Med, Johns Hopkins Oncol Ctr, Baltimore, MD 21205 USA

[3] Columbia Presbyterian Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA

[4] N Essex Hlth Author, Witham, Essex, England

[5] Univ Utrecht Hosp, Utrecht, Netherlands

[6] Inst Med Informat, Leipzig, Germany

[7] Hosp Clin Barcelona, Barcelona, Spain

[8] Christie Hosp & Holt Radium Inst, Manchester M20 9BX, Lancs, England

[9] Ctr Hosp Lyon Sud, Lyon, France

[10] Med Klin & Poliklin, Kiel, Germany

[11] Oncol Clin, Brussels, Belgium

[12] Univ Nebraska, Med Ctr, Omaha, NE USA

[13] Ctr Leon Berard, F-69373 Lyon, France

来源：

ANNALS OF ONCOLOGY | 1999年 / 10卷 / 01期

关键词：

B-cell; bone marrow transplantation; high risk; peripheral blood stem cells; poor prognosis;

D O I：

10.1023/A:1008397220178

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

[No abstract available]

引用

页码：13 / 19

页数：7

共 33 条

[1]

Bosly A., 1997, Blood, V90, p594A

[2]

CHESON B, UNPUB INT WORKSH STA

[3]

CONSENSUS CONFERENCE ON INTENSIVE CHEMOTHERAPY PLUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN MALIGNANCIES, LYON, JUNE 4-6, 1993 [J].

COIFFIER, B ;

PHILIP, T ;

BURNETT, AK ;

SYMANN, ML .

ANNALS OF ONCOLOGY, 1994, 5 (01) :19-23

[4]

Damiani D, 1997, BLOOD, V90, P36

[5]

High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma [J].

Gianni, AM ;

Bregni, M ;

Siena, S ;

Brambilla, C ;

DiNicola, M ;

Lombardi, F ;

Gandola, L ;

Tarella, C ;

Pileri, A ;

Ravagnani, F ;

Valagussa, P ;

Bonadonna, G ;

Stern, AC ;

Magni, M ;

Caracciolo, D .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (18) :1290-1297

[6]

IMMUNOLOGICAL PURGING OF MARROW ASSESSED BY PCR BEFORE AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR B-CELL LYMPHOMA [J].

GRIBBEN, JG ;

FREEDMAN, AS ;

NEUBERG, D ;

ROY, DC ;

BLAKE, KW ;

WOO, SD ;

GROSSBARD, ML ;

RABINOWE, SN ;

CORAL, F ;

FREEMAN, GJ ;

RITZ, J ;

NADLER, LM .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (22) :1525-1533

[7]

Haioun C, 1998, Ann Oncol, V9 Suppl 1, pS5

[8]

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: Updated results of the prospective study LNH87-2 [J].

Haioun, C ;

Lepage, E ;

Gisselbrecht, C ;

Bastion, Y ;

Coiffier, B ;

Brice, P ;

Bosly, A ;

Dupriez, B ;

Nouvel, C ;

Tilly, H ;

Lederlin, P ;

Biron, P ;

Briere, J ;

Gaulard, P ;

Reyes, F .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :1131-1137

[9]

COMPARISON OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION WITH SEQUENTIAL CHEMOTHERAPY FOR INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA IN FIRST COMPLETE REMISSION - A STUDY OF 464 PATIENTS [J].

HAIOUN, C ;

LEPAGE, E ;

GISSELBRECHT, C ;

COIFFIER, B ;

BOSLY, A ;

TILLY, H ;

MOREL, P ;

NOUVEL, C ;

HERBRECHT, R ;

DAGAY, MF ;

GAULARD, P ;

REYES, F .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (12) :2543-2551

[10]

Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: Hematologic recovery and costs - A randomized, controlled trial [J].

Hartmann, O ;

LeCorroller, AG ;

Blaise, D ;

Michon, J ;

Philip, I ;

Norol, F ;

Janvier, M ;

Pico, JL ;

Baranzelli, MC ;

Rubie, H ;

Coze, C ;

Pinna, A ;

Meresse, V ;

Benhamou, E .

ANNALS OF INTERNAL MEDICINE, 1997, 126 (08) :600-+

← 1 2 3 4 →